{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Fotemustine",
  "nciThesaurus": {
    "casRegistry": "92118-27-9",
    "chebiId": "",
    "chemicalFormula": "C9H19ClN3O5P",
    "definition": "A chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of guanine, resulting in N1-guanine and N3-cytosine cross linkages, inhibition of DNA synthesis, cell cycle arrest, and finally apoptosis. This agent is lipophilic and crosses the blood-brain barrier.",
    "fdaUniiCode": "GQ7JL9P5I2",
    "identifier": "C1106",
    "preferredName": "Fotemustine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C699"
    ],
    "synonyms": [
      "1-[N-(2-chloroethyl)-N-nitrosoureido]ethylphosphonic acid diethyl ester",
      "FOTEMUSTINE",
      "Fotemustine",
      "Muphoran",
      "S 10036",
      "[1-[[[(2-chloroethyl)nitrosamino]-carbonyl]amino]ethyl]phosphonic acid diethyl ester",
      "diethyl[1-[3-(2-chloroethyl)-3-nitrosoureido]ethyl]phosphonate",
      "fotemustine"
    ]
  }
}